Correlation Between Pardes Biosciences and Champions Oncology

Can any of the company-specific risk be diversified away by investing in both Pardes Biosciences and Champions Oncology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pardes Biosciences and Champions Oncology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Pardes Biosciences and Champions Oncology, you can compare the effects of market volatilities on Pardes Biosciences and Champions Oncology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pardes Biosciences with a short position of Champions Oncology. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pardes Biosciences and Champions Oncology.

Diversification Opportunities for Pardes Biosciences and Champions Oncology

0.0

Correlation Coefficient

Pardes Biosciences  Champions Oncology

Pay attention - limited upside

The 3 months correlation between Pardes and Champions is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Pardes Biosciences and Champions Oncology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Champions Oncology and Pardes Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pardes Biosciences are associated (or correlated) with Champions Oncology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Champions Oncology has no effect on the direction of Pardes Biosciences i.e., Pardes Biosciences and Champions Oncology go up and down completely randomly.

Pair Corralation between Pardes Biosciences and Champions Oncology

If you would invest  452.00  in Champions Oncology on November 29, 2024 and sell it today you would earn a total of  574.00  from holding Champions Oncology or generate 126.99% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Pardes Biosciences  vs.  Champions Oncology

Pardes Biosciences

Risk-Adjusted Performance

Very Weak

Over the last 90 days Pardes Biosciences has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Pardes Biosciences is not utilizing all of its potentials. The latest stock price uproar, may contribute to short-horizon losses for the private investors.

Champions Oncology

Risk-Adjusted Performance

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in Champions Oncology are ranked lower than 19 (%) of all global equities and portfolios over the last 90 days. Even with relatively unfluctuating fundamental drivers, Champions Oncology reported solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Pardes Biosciences and Champions Oncology

The main advantage of trading using opposite Pardes Biosciences and Champions Oncology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pardes Biosciences position performs unexpectedly, Champions Oncology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Champions Oncology will offset losses from the drop in Champions Oncology's long position.

The idea behind Pardes Biosciences and Champions Oncology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.